Table 1

Baseline clinical characteristics of study participants (N = 94)
      Variable Prevalence Mean/Median SD/IQR
Age (years) 63.7 14
Male sex 56%
Body mass index (kg/m2) 31.7 9.3
eGFR (ml/min/1.73 m2) 25.1 11.9
UACR (mg/mmol) (N = 88) 22.2 4-118
Hypertension (N = 93) 94.7%
Systolic Blood Pressure (mmHg) (N = 93) 131.8 17.4
Diastolic Blood Pressure (mmHg) (N = 93) 73.3 11.8
Diabetes mellitus 39%
Metabolic Syndrome 81%
HOMA-IR (uU/mL) (N = 72) 2.19 1.19–3.94
Glucose (mmol/l) 5.7 5.2–6.7
Hemoglobin A1C% (N = 93) 6.1 5.6–7.2
Calcium (mmol/l) 2.30 .022
Phosphorus (mmol/l) 1.29 0.27
Albumin (g/l) 37.3 3.6
Total cholesterol (mmol/l) (N = 93) 4.15 1.29
HDL cholesterol (mmol/l) (N = 93) 1.01 0.34
LDL cholesterol (mmol/l) (N = 92) 2.37 1.05
Triglycerides (mmol/l) (N = 93) 1.8 1.06
hsCRP (mg/l) (N = 93) 3.00 1.25–6.1
25-Hydroxy Vitamin D (nmol/l) 54.67 44.9–69.1
1,25-Dihydroxyvitamin D (pmol/l) 49.6 30.8–71.5
FGF-23 (RU/ml) 150.8 73.4–305.3
Fetuin (g/L) (N = 93) 0.613 0.13
Osteoprotegerin (pmol/L) 4.09 1.86
Interleukin – 6 (pg/mL) (N = 93) 1.89 0.67–5.30
Coronary artery calcification score (AU) 192 24–873
ssEFV (cm3) 5.03 2.4
ssEFA (cm2) 20.1 9.77

eGFR = estimated glomerular filtration rate; UACR = urinary albumin to creatinine ratio; HOMA-IR = homeostasis model assessment of insulin resistance; HDL = high density lipoprotein; LDL = low density lipoprotein; hsCRP = high sensitivity C-reactive protein; FGF-23 = fibroblast growth factor −23; AU = Agatston units; ssEFV = single slice epicardial fat volume at the level of the left main coronary artery (LMCA); ssEFA = single slice epicardial fat area at the level of the LMCA; SD = standard deviation; IQR = interquartile range.

Kerr et al.

Kerr et al. BMC Nephrology 2013 14:26   doi:10.1186/1471-2369-14-26

Open Data